Cookies on PerkinElmer
PerkinElmer uses cookies to ensure that we give you the best experience possible on our website. This may include cookies from third party websites. If you continue without changing your settings, we will assume that you consent to receive cookies from this website. You can change your cookie settings at any time. To learn more, please review our cookie policy, which includes information on how to manage your cookies.

For Safer Pregnancies

Pre-eclampsia, a condition that occurs during pregnancy and is characterized by high-blood pressure, can lead to harmful or even fatal complications for both mother and child. Fortunately, our latest screening solutions allow pregnant women and their OBGYNs to identify a risk for this condition as early as the first trimester when treatment can be administered for better outcomes. In fact, a recent study showed that women who are identified as "at-risk" can reduce the rate of pre-eclampsia with a simple regimen of aspirin. In addition to our pre-eclampsia kits,we offer other technologies that aid in everything from fertility research to healthier pregnancies.

Pre-eclampsia Then and Now


Pre-eclampsia Then and Now

Better Stories

Better Products

DELFIA/AutoDELFIA PlGF 1-2-3 kit

PIGF 1-2-3 Assay (pre-eclampsia screening kit)

In all three trimesters best results are obtained by using the PlGF test result together with results for other markers, such as maternal history, ultrasound (uAD) and mean arterial blood pressure (MAP); the same combination of markers is suitable for use at every stage of pregnancy.

DELFIA Xpress random access platform for prenatal screening

DELFIA Xpress

Our random access prenatal screening platform streamlines workflows in laboratories and clinics. Multiple samples can be processed at once and results are ready in 30 minutes. A full range of first- and second-trimester screening kits are available to support all of today's pre-natal screening strategies, from early identification of pre-eclampsia to screening for aneuploidies.

VICTOR2 D Instrument (Newborn Screening)

VICTOR2 D Flourometer

The ideal measurement platform for low volume laboratories, the Easy-to-use and reliable, VICTOR2 D provides start-up screening programs with the right balance of control and cost-effectiveness.

Innovative Thinking


Kypros Nicolaides

Innovation in Pre-eclampsia Research - ASPRE Trial Results

Kypros Nicolaides, Professor of Fetal Medicine, King’s College, London has carried out extensive research in fetal diagnosis and therapy, leading to the publication of more than 1,200 peer-reviewed papers in scientific journals. He has provided training in Fetal Medicine to more than 500 doctors from 50 countries and has encouraged many more young doctors to undertake research in the field. In 1995, he founded the Fetal Medicine Foundation, which has donated more than £15 million to promote research and training in Fetal Medicine throughout the World.

Learn more about the ASPRE Trial

Want to hear more about pre-eclampsia screening solutions?


Start the conversation today



Discover More...